Maxime Dely: A Meaningful Journey of 14 years in Blood Transfusion
Maxime Dely, Therapeutic Solutions Sales Consultant at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
“14 years in blood transfusion: a meaningful journey
It has already been 14 years since I started working in the field of blood transfusion.
Right after graduating, I had the opportunity to enter this demanding field directly, without imagining how much it would become a daily source of human
enrichment and scientific stimulation.
This profession means meeting people with unique life stories: patients, donors, physicians, nurses, caregivers… so many faces, cultures, and experiences that
constantly remind us of the strength of collective commitment.
At the heart of it all is this invisible link between a donor and a patient – no meeting, no words, yet a life-changing impact.
A remarkable form of silent solidarity
It is also a field in constant evolution: therapeutic innovations, new cell recovery techniques, continuous improvement of practices, and medical advances.
Each step reinforces my conviction that I work in an area where learning never stops.
Throughout this ‘short career,’ I have also had the chance to discover around thirty countries, explore fascinating cultures, and broaden both my view of the world and my profession.
The journey continues with the same curiosity, the same passion… and still just as much happiness.”
More posts featuring Maxime Dely on Hemostasis Today
-
Jun 5, 2026, 16:13Why Do Patients with Similar Conditions Bleed Differently? – EAHAD
-
Jun 5, 2026, 15:59Erica Brock: A Closer Look at Our Care Model for Individuals and Families Affected by Bleeding Disorders
-
Jun 5, 2026, 15:53Andjelka Stones: Key Findings on Hemophilia A Gene Therapy
-
Jun 5, 2026, 15:52Atieh Karimzadeh: Romiplostim Shows High Response and Reduced Bleeding in Pediatric HSCT
-
Jun 5, 2026, 15:50Venugopalan Unni: D-Dimer and Pulmonary Embolism
-
Jun 5, 2026, 15:48Surbhi Singh: Platelet Satellitism – When Platelets Cluster Around Neutrophils and Mimic Thrombocytopenia
-
Jun 5, 2026, 15:39Wolfgang Miesbach: CMA CAR-T Induces Immune Reset and Durable Remission in Refractory ITP – EHA 2026 Late-Breaking Update
-
Jun 5, 2026, 15:34Ney Carter Borges: Low-Dose Rivaroxaban in Advanced Chronic Kidney Disease – Lessons From the TRACK Trial
-
Jun 5, 2026, 15:29Nethuki Kulasinghe: Sequential Anticoagulation in Postpartum Iliocaval Thrombosis With Submassive PE and HIT